HEMOSEEQ Trademark

Trademark Overview

On Wednesday, June 17, 2026, a trademark application was filed for HEMOSEEQ with the United States Patent and Trademark Office. The USPTO has given the HEMOSEEQ trademark a serial number of 99892157. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, June 17, 2026. This trademark is owned by GoPath Global Inc.. The HEMOSEEQ trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical testing services and information in the field of cancer research and disease classification at the molecular level
hemoseeq

General Information

Serial Number99892157
Word MarkHEMOSEEQ
Filing DateWednesday, June 17, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, June 17, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkHEMO SEQ
Pseudo MarkBLOOD SEQUENCING
Pseudo MarkHEMO SEQUENCING
Pseudo MarkBLOOD SEQUENCE
Pseudo MarkHEMO SEQUENCE
Goods and ServicesProviding medical testing services and information in the field of cancer research and disease classification at the molecular level

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 17, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGoPath Global Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBuffalo Grove, IL 60089
US

Trademark Events

Event DateEvent Description
Wednesday, June 17, 2026NEW APPLICATION ENTERED
Wednesday, June 17, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

hemoseeq disease research classification molecular level cancer field medical testing services